[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-368293-105":59,"doc-detail-368293-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","estimating-the-burden-of-false-positives-and-implementation-costs-from-adding-multiple-single-cancer-tests-or-a-single-multi-cancer-test-to-standard-of-care-screening","Estimating the Burden of False Positives and Implementation Costs From Adding Multiple Single Cancer Tests or a Single Multi-Cancer Test to Standard-Of-Care Screening","","Blood-based cancer screening can be improved via two strategies: single-cancer early detection (SCED) tests for one cancer each, which tend to yield higher false-positive rates, and multi-cancer early detection (MCED) tests that target multiple cancers at once with a low false-positive rate. A comparative framework was developed for general-population screening efficiency and downstream testing costs. Hypothetical systems were simulated over one year alongside standard USPSTF screening for 100,000 U.S. adults.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/estimating-the-burden-of-false-positives-and-implementation-costs-from-adding-multiple-single-cancer-tests-or-a-single-multi-cancer-test-to-standard-of-care-screening/368293/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/estimating-the-burden-of-false-positives-and-implementation-costs-from-adding-multiple-single-cancer-tests-or-a-single-multi-cancer-test-to-standard-of-care-screening/368293.png","ImageObject",300,407,{"name":92,"@type":93},"Levi","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-14","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What problem does the study address about SCED and MCED blood-based cancer screening?","Question",{"text":112,"@type":113},"It addresses the difficulty of comparing two different screening paradigms: SCED’s higher false-positive rate versus MCED’s broader targeting with low false positives and different efficiency and cost implications.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were the SCED-10 and MCED-10 screening systems constructed?",{"text":117,"@type":113},"SCED-10 used 10 hypothetical single-cancer tests, each targeting one cancer type, while MCED-10 used one hypothetical multi-cancer test targeting the same 10 cancer types.",{"name":119,"@type":110,"acceptedAnswer":120},"What were the main findings when the strategies were evaluated over one year?",{"text":121,"@type":113},"SCED-10 detected more cancers than MCED-10 but produced far more diagnostic investigations in people without cancer, with substantially lower efficiency, higher costs, and much larger cumulative false-positive burden.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},368293,1790907971,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":41,"preview_page_count":19,"preview_urls":145},7971461740909,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","Cancer Medicine  \nRESEARCH ARTICLE  OPEN ACCESS   \nEstimating the Burden of False Positives and Implementation Costs From Adding Multiple Single Cancer Tests or a Single Multi-Cancer Test to Standard-Of-Care Screening  \nSarina Madhavan1,2 | Allan Hackshaw3 | Earl Hubbell2 | Ellen T. Chang2  | Anuraag Kansal2 | Christina A. Clarke1,2  \n1Massachusetts General Hospital, Boston, Massachusetts, USA | 2GRAIL, Inc. , Menlo Park, California, USA | 3University College of London, London, UK Correspondence: Christina A. Clarke ([cclarke@grailbio.com](cclarke@grailbio.com))  \nReceived: 30 April 2024 | Revised: 6 January 2025 | Accepted: 7 March 2025  \nFunding: This work was supported by GRAIL, Inc.  \nKeywords: blood-based testing | cancer prevention | cancer screening  \nABSTRACT  \nBackground: Blood-based tests present a promising strategy to enhance cancer screening through two distinct approaches. In the traditional paradigm of “one test for one cancer”, single-cancer early detection (SCED) tests a feature high true positive rate (TPR) for individual cancers, but high false-positive rate (FPR). Whereas multi-cancer early detection (MCED) tests simultaneously target multiple cancers with one low FPR, offering a new “one test for multiple cancers” approach. However, comparing these two approaches is inherently non-intuitive. We developed a framework for evaluating and comparing the efficiency and downstream costs of these two blood-based screening approaches at the general population level.  \nMethods: We developed two hypothetical screening systems to evaluate the performance efficiency of each blood-based screening approach. The “SCED-10” system featured 10 hypothetical SCED tests, each targeting one cancer type; the “MCED-10” system included a single hypothetical MCED test targeting the same 10 cancer types. We estimated the number of cancers detected, cumulative false positives, and associated costs of obligated testing for positive results for each system over 1 year when added to existing USPSTF-recommended cancer screening for 100,000 US adults aged 50–79.  \nResults: Compared with MCED-10, SCED-10 detected 1.4× more cancers (412 vs. 298), but had 188× more diagnostic investigations in cancer-free people (93,289 vs. 497), lower efficiency (positive predictive value: 0.44% vs. 38%; number needed to screen: 2062 vs. 334), 3.4× the cost ($329 M vs. $98 M), and 150× higher cumulative burden of false positives per annual round of screening (18 vs. 0.12) .  \nConclusions: A screening system for average-risk individuals using multiple SCED tests has a higher rate of false positives and associated costs compared with a single MCED test. A set of SCED tests with the same sensitivity as standard-of-care screening detects only modestly more cancers than an MCED test limited to the same set of cancers.  \n\n| Ellen T. Chang affiliation at the time of the study. |\n| --- |\n| This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.\u003Cbr>© 2025 The Author(s). Cancer Medicine published by John Wiley & Sons Ltd. |\n\nCancer Medicine, 2025; 14:e70776 1 of 12  \n[https://doi.org/10.1002/cam4.70776](https://doi.org/10.1002/cam4.70776)  \nFIGURE 1 | Schematic illustrating the concept of single-cancer early detection (SCED) based on one test per cancer, and multi-cancer early detection (MCED) based on one test per individual person.  \n1 | Introduction  \nThe rapid emergence of both single-cancer and multi-cancer blood-based screening tests compels a reassessment of the established evaluation framework for cancer screening technologies. These blood-based tests hold the promise to identify many of the ~85% of cancers not covered or detected by guidelinerecommended screening [1, 2] . Single-cancer early detection (SCED) and multi-cancer early detection (MCED) tests present two distinct approaches for improving cancer outcomes t","cbCaihY1UIVWn3Qr","https://ap.wps.com/l/cbCaihY1UIVWn3Qr","pdf",827412,12,"English","# Introduction\n## Background: SCED vs MCED blood-based screening\n# Methods\n## Hypothetical screening systems and evaluation approach\n# Results\n## Cancer detection, false positives, and cost comparisons\n# Conclusions\n## Trade-offs between SCED and MCED for average-risk screening","[{\"question\":\"What problem does the study address about SCED and MCED blood-based cancer screening?\",\"answer\":\"It addresses the difficulty of comparing two different screening paradigms: SCED’s higher false-positive rate versus MCED’s broader targeting with low false positives and different efficiency and cost implications.\"},{\"question\":\"How were the SCED-10 and MCED-10 screening systems constructed?\",\"answer\":\"SCED-10 used 10 hypothetical single-cancer tests, each targeting one cancer type, while MCED-10 used one hypothetical multi-cancer test targeting the same 10 cancer types.\"},{\"question\":\"What were the main findings when the strategies were evaluated over one year?\",\"answer\":\"SCED-10 detected more cancers than MCED-10 but produced far more diagnostic investigations in people without cancer, with substantially lower efficiency, higher costs, and much larger cumulative false-positive burden.\"}]","Estimating the Burden of False Positives and Implementation Costs From Adding Multiple Single Cancer Tests or a Single Multi-Cancer Test to Standard-Of-Care Screening | PDF",1790176086,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d24dd7efaaf07a0c564e388bda2470bd.webp",983,1291,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/aa8750066d0d7d491f6a018db0593130.webp",982,1290,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/101c6793bb1753b63d71c52741935a17.webp",981,1289,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c61edb47d0cf90a9021caae5dc46444b.webp",980,1287]